![Michael Clifford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Clifford
Direktor/Vorstandsmitglied bei SynDevRx, Inc.
Aktive Positionen von Michael Clifford
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Michael Clifford
Ausbildung von Michael Clifford
Cornell University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sektoral
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Börse
- Insiders
- Michael Clifford
- Erfahrung